4.105
price up icon2.76%   0.115
 
loading
前日終値:
$3.99
開ける:
$3.96
24時間の取引高:
1.04M
Relative Volume:
1.21
時価総額:
$508.52M
収益:
$69.56M
当期純損益:
$-240.05M
株価収益率:
-1.3915
EPS:
-2.95
ネットキャッシュフロー:
$-121.90M
1週間 パフォーマンス:
+3.54%
1か月 パフォーマンス:
-0.73%
6か月 パフォーマンス:
+108.12%
1年 パフォーマンス:
+111.34%
1日の値動き範囲:
Value
$3.95
$4.135
1週間の範囲:
Value
$3.91
$4.29
52週間の値動き範囲:
Value
$1.05
$4.80

Adc Therapeutics Sa Stock (ADCT) Company Profile

Name
名前
Adc Therapeutics Sa
Name
セクター
Healthcare (1139)
Name
電話
41 21 653 02 00
Name
住所
BIOPOLE, EPALINGES
Name
職員
263
Name
Twitter
Name
次回の収益日
2025-03-21
Name
最新のSEC提出書
Name
ADCT's Discussions on Twitter

ADCT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ADCT
Adc Therapeutics Sa
4.105 494.27M 69.56M -240.05M -121.90M -2.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
435.06 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
761.11 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
438.15 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
922.65 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
200.22 42.58B 447.02M -1.18B -906.14M -6.1812

Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-08 開始されました Stephens Overweight
2024-05-30 開始されました Cantor Fitzgerald Overweight
2024-03-28 開始されました Guggenheim Buy
2023-08-10 アップグレード JP Morgan Underweight → Neutral
2023-04-24 ダウングレード BofA Securities Neutral → Underperform
2022-12-06 開始されました CapitalOne Overweight
2022-11-09 ダウングレード BofA Securities Buy → Neutral
2022-09-21 開始されました JP Morgan Overweight
2022-09-09 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-11-09 開始されました Wolfe Research Outperform
2021-08-17 再開されました Jefferies Buy
2021-08-09 開始されました RBC Capital Mkts Outperform
2021-06-15 開始されました Cantor Fitzgerald Overweight
2020-12-03 開始されました Stifel Hold
2020-10-29 開始されました H.C. Wainwright Buy
2020-06-09 開始されました BofA/Merrill Buy
2020-06-09 開始されました Cowen Outperform
すべてを表示

Adc Therapeutics Sa (ADCT) 最新ニュース

pulisher
Nov 20, 2025

How ADC Therapeutics SA Common Shares stock expands through international markets2025 Momentum Check & Expert Curated Trade Setup Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How cyclical is ADC Therapeutics SA Common Shares stock compared to rivalsJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can ADC Therapeutics SA stock attract ESG capital inflowsMarket Sentiment Report & Weekly Sector Rotation Insights - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Should I buy ADC Therapeutics SA Common Shares stock before earnings season2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Chart overlay techniques for tracking ADC Therapeutics SAQuarterly Portfolio Review & High Accuracy Swing Trade Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will ADC Therapeutics SA Common Shares stock draw ESG focused fundsJuly 2025 Reactions & Daily Profit Focused Stock Screening - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Adc Therapeutics at Jefferies Conference: Strategic Expansion Plans By Investing.com - Investing.com UK

Nov 19, 2025
pulisher
Nov 19, 2025

What indicators show strength in ADC Therapeutics SAJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Will ADC Therapeutics SA Common Shares stock beat Nasdaq index returnsEarnings Risk Summary & Expert Curated Trade Ideas - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Is ADC Therapeutics SA stock a defensive play in 20252025 Retail Activity & Fast Gain Swing Trade Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

ADC Therapeutics (ADCT) Upgraded to Buy: Here's What You Should Know - sharewise.com

Nov 18, 2025
pulisher
Nov 17, 2025

Will ADC Therapeutics SA stock deliver long term returnsJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

ADC Therapeutics (ADCT) Secures PIPE Financing, Price Target Adjusted - MSN

Nov 16, 2025
pulisher
Nov 16, 2025

Is ADC Therapeutics SA stock bottoming outJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

How to track smart money flows in ADC Therapeutics SAWeekly Stock Summary & High Accuracy Investment Entry Signals - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Wall Street Zen Upgrades ADC Therapeutics (NYSE:ADCT) to "Hold" - MarketBeat

Nov 16, 2025
pulisher
Nov 15, 2025

Is it time to cut losses on ADC Therapeutics SACPI Data & Low Volatility Stock Recommendations - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is ADC Therapeutics SA stock a top pick in earnings seasonQuarterly Profit Review & Community Driven Trade Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Why analysts upgrade ADC Therapeutics SA stockEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

How institutional ownership impacts ADC Therapeutics SA stockTreasury Yields & Fast Gaining Stock Reports - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

ADC Therapeutics SA Common Shares (NY: ADCT - FinancialContent

Nov 14, 2025
pulisher
Nov 14, 2025

FY2025 EPS Estimates for ADCT Increased by Cantor Fitzgerald - MarketBeat

Nov 14, 2025
pulisher
Nov 14, 2025

ADC Therapeutics S.A. (ADCT) Eyes Billion Dollar Opportunity with ZYNLATA Indication Expansion - MSN

Nov 14, 2025
pulisher
Nov 13, 2025

[SCHEDULE 13G/A] ADC Therapeutics SA SEC Filing - Stock Titan

Nov 13, 2025
pulisher
Nov 13, 2025

Momentum divergence signals in ADC Therapeutics SA chartTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 13, 2025

Adc Therapeutics Sa (ADCT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$39.04
price up icon 1.64%
$30.68
price up icon 2.13%
$102.37
price up icon 0.68%
$96.31
price down icon 0.70%
biotechnology ONC
$347.71
price down icon 0.53%
$200.38
price up icon 0.08%
大文字化:     |  ボリューム (24 時間):